Comparison

Lemborexant European Partner

Item no. HY-16725-100mg
Manufacturer MedChem Express
CASRN 1369764-02-2
Amount 100 mg
Quantity options 100 mg 10 mM x 1 mL 10 mg 25 mg 50 mg 5 mg
Category
Type Inhibitor
Specific against other
Purity 99.19%
Citations bioRxiv. 2020 May.
Smiles O=C([C@H]1[C@@](C2=CC=CC(F)=C2)(COC3=CN=C(C)N=C3C)C1)NC4=NC=C(F)C=C4
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias E-2006
Available
Product Description
Lemborexant (E-2006) is a reversible, competitive and orally active dual antagonist of the orexin OX1 and OX2 receptors with IC50 values of 6.1 nM and 2.6 nM, respectively. Lemborexant can be treated insomnia.
StorageTemperature
Powder -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month
MolecularWeight
410.42
Clinical_Information
Launched
Research_Area
Neurological Disease
Solubility
DMSO : 100 mg/mL (243.65 mM; Need ultrasonic)
Target
Orexin Receptor (OX Receptor)
Isoform
OX1; OX2
Pathway
GPCR/G Protein; Neuronal Signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close